|
|
||||||||
Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama 35294
Three experiments compared the potency of the type A cholecystokinin (CCKA)-receptor antagonist devazepide for increasing intake of 30% sucrose when injected into the superior pancreaticoduodenal (SPD) artery (SPD group) or jugular vein (IV group). In experiment 1, 15 min of sucrose intake in adult, male Sprague-Dawley rats after 6 h of food deprivation was increased by devazepide (20 µg/kg) administered into the SPD artery whether given alone or in conjunction with cholecystokinin octapeptide (CCK-8, 2 µg/kg ip). Devazepide had no effect in the IV group. In experiment 2, injection of 8, 20, and 50 µg/kg of devazepide into the SPD artery increased sucrose intake of nondeprived rats. Only the highest dose was effective in the IV group. On subsequent tests, administration of 1 µg/kg of CCK-8 significantly suppressed intake only in the SPD group. In experiment 3, nondeprived rats with SPD artery and jugular vein catheters were tested in a within-subjects design. Devazepide (20 µg/kg) increased sucrose intake after injection into the SPD artery, but not into the jugular vein. In experiment 4, intraduodenal devazepide (8, 20, and 50 µg/kg) had no effect. These results indicate that CCKA receptors within the SPD arterial bed mediate the satiating action of CCK, consistent with local action of duodenal CCK.
devazepide; duodenum; endogenous cholecystokinin; rat; satiety
This article has been cited by other articles:
![]() |
S. Eisen, R. J. Phillips, N. Geary, E. A. Baronowsky, T. L. Powley, and G. P. Smith Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R456 - R462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Chi, G. Fan, and E. A. Fox Increased short-term food satiation and sensitivity to cholecystokinin in neurotrophin-4 knock-in mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1044 - R1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Chi and T. L. Powley c-Kit mutant mouse behavioral phenotype: altered meal patterns and CCK sensitivity but normal daily food intake and body weight Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1170 - R1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Reidelberger, D. Heimann, L. Kelsey, and M. Hulce Effects of peripheral CCK receptor blockade on feeding responses to duodenal nutrient infusions in rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R389 - R398. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, S. Cardin, V. Martinez, Y. Tache, and K. C. K. Lloyd Duodenal loading with glucose induces Fos expression in rat brain: selective blockade by devazepide Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R667 - R674. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |